joy jili slot
Palo Alto Networks stock price rose by 26% in 2024 as demand for cybersecurity continues rising globally. It also jumped because of the artificial intelligence tailwinds that have pushed other companies in the industry sharply higher. Its stock rose to a record high of $207 and then pulled back to the current $186. So, is PANW a good company to buy in 2025? Advertisement Are you looking for signals & alerts from pro-traders? Sign-up to Invezz SignalsTM for FREE. Takes 2 mins. PANW is a good growth company Copy link to section Palo Alto Networks is one of the fastest-growing companies in the cybersecurity industry. It offers network security, cloud security, and artificial intelligence solutions. The company takes a hybrid approach, offering hardware solutions like hardware firewalls and software solutions through a subscription model. Advertisement Palo Alto Networks' business has done well in the past few years as it added thousands of customers globally. Its top clients include Caesars Entertainment, Salesforce, ADT, Michelin, and Better Mortgage. PANW's business has... Crispus Nyaga
To the Editor: This morning as I read the Ukiah Daily Journal, when I came to the editorial cartoon by Stahler calling Trump’s cabinet picks STUPID and showing Trump smirking as if he had gotten one over on everybody I just couldn’t restrain myself any longer and am writing this letter on behalf of the silent minority of Mendocino county and the silent majority who spoke in the recent election. I won’t greatly articulate why Trump was elected and Tommy Hine in his last letter said it well. “Democrats. Party of long noses.” Or for another source from the left speaking to their party, read the recent column by Bill Maher in the New York Times, “There’s no monopoly on stupid” and he states that the Democratic party had become a “Portlandia sketch.” I’m not naive and don’t think that this next four years is going to fix all the problems of our country, especially the economic national debt of 36 trillion dollars. This I know though that the average working class American is sick of woke ideology teaching that there is more than two genders and imposing these values on our children. You claim to believe in science and it doesn’t get more basic than this. We are sick of having these values force fed through our educational institutions on these same children further confusing the difficult transition from childhood through puberty. We are sick that there are puberty blockers being given to children and worse, mutilation of their bodies. We are sick that one penny of our tax dollars is spent to provide this for prisoners. We are sick that men who call themselves women are competing against women in women’s sports. Women have fought too long and hard for their rights to see them stolen by a bunch of cowards. I had a dream about a year ago wherein I remembered the scene from the original Titanic movie that I watched when I was a child. The one where a man disguised himself as a woman to save himself because he was a coward. Unless you think I am exaggerating there are tampon dispensers in the boys room at Eagle Peak middle school. We are sick of parental rights being taken away by the government. We are sick of illegal immigration being called immigration and having a porous border. Are we a sovereign nation or not? We are sick of having electric mandates force fed on us when we are still looking for and trying to find alternative energy sources. The problem with solar and wind without our current carbon and nuclear sources, is storage. That is why the tax incentives for solar have gone away because we don’t need more production as much as we need storage. We understand that electricity to power these vehicles has to be produced by some other source. We are sick of the emphasis on “Climate change” as if it is the greatest threat to humanity. Personally having grown up under the threat of nuclear annihilation and this threat which is still quite alive scares me way more than the idea that we won’t find a way to produce the world’s energy demands. Necessity is the mother of invention, we need to diligently keep working on alternatives, but you can’t stop the means of production in the mean time. That is a major effect of what destroyed the economy during the pandemic as small business was forced to shutdown and it has been a huge contributor to the huge inflation of the last four years. Poor nations are struggling to produce their energy needs with our current technologies so don’t count on them to really be on board to the current solutions that aren’t. I don’t read the UDJ because I like to be insulted but because I like to keep up on local news, events, and obituaries. I am part of this community and have been since 1975. Both of my children were born and raised here and I love this community. If you disagree with me that is fine. I will gladly have a conversation with anyone of opposing viewpoints and do it with respect and kindness. -Randy Dorn, Redwood ValleyUnlike scores of people who scrambled for the blockbuster drugs Ozempic and Wegovy to lose weight in recent years, Danielle Griffin had no trouble getting them. The 38-year-old information technology worker from New Mexico had a prescription. Her pharmacy had the drugs in stock. And her health insurance covered all but $25 to $50 of the monthly cost. For Griffin, the hardest part of using the new drugs wasn’t access. It was finding out that the much-hyped medications didn’t really work for her. “I have been on Wegovy for a year and a half and have only lost 13 pounds,” said Griffin, who watches her diet, drinks plenty of water and exercises regularly. “I’ve done everything right with no success. It’s discouraging.” In clinical trials, most participants taking Wegovy or Mounjaro to treat obesity lost an average of 15% to 22% of their body weight — up to 50 pounds or more in many cases. But roughly 10% to 15% of patients in those trials were “nonresponders” who lost less than 5% of their body weight. Now that millions of people have used the drugs, several obesity experts told The Associated Press that perhaps 20% of patients — as many as 1 in 5 — may not respond well to the medications. It's a little-known consequence of the obesity drug boom, according to doctors who caution eager patients not to expect one-size-fits-all results. “It's all about explaining that different people have different responses,” said Dr. Fatima Cody Stanford, an obesity expert at Massachusetts General Hospital The drugs are known as GLP-1 receptor agonists because they mimic a hormone in the body known as glucagon-like peptide 1. Genetics, hormones and variability in how the brain regulates energy can all influence weight — and a person's response to the drugs, Stanford said. Medical conditions such as sleep apnea can prevent weight loss, as can certain common medications, such as antidepressants, steroids and contraceptives. “This is a disease that stems from the brain,” said Stanford. “The dysfunction may not be the same” from patient to patient. Despite such cautions, patients are often upset when they start getting the weekly injections but the numbers on the scale barely budge. “It can be devastating,” said Dr. Katherine Saunders, an obesity expert at Weill Cornell Medicine and co-founder of the obesity treatment company FlyteHealth. “With such high expectations, there’s so much room for disappointment.” That was the case for Griffin, who has battled obesity since childhood and hoped to shed 70 pounds using Wegovy. The drug helped reduce her appetite and lowered her risk of diabetes, but she saw little change in weight. “It’s an emotional roller coaster,” she said. “You want it to work like it does for everybody else.” The medications are typically prescribed along with eating behavior and lifestyle changes. It’s usually clear within weeks whether someone will respond to the drugs, said Dr. Jody Dushay, an endocrine specialist at Beth Israel Deaconess Medical Center. Weight loss typically begins right away and continues as the dosage increases. For some patients, that just doesn't happen. For others, side effects such as nausea, vomiting and diarrhea force them to halt the medications, Dushay said. In such situations, patients who were counting on the new drugs to pare pounds may think they’re out of options. “I tell them: It's not game over,” Dushay said. Trying a different version of the new class of drugs may help. Griffin, who didn't respond well to Wegovy, has started using Zepbound, which targets an additional hormone pathway in the body. After three months of using the drug, she has lost 7 pounds. “I'm hoping it's slow and steady,” she said. Other people respond well to older drugs, the experts said. Changing diet, exercise, sleep and stress habits can also have profound effects. Figuring out what works typically requires a doctor trained to treat obesity, Saunders noted. “Obesity is such a complex disease that really needs to be treated very comprehensively,” she said. “If what we’re prescribing doesn’t work, we always have a backup plan.” ___ The Associated Press Health and Science Department receives support from the Howard Hughes Medical Institute’s Science and Educational Media Group. The AP is solely responsible for all content. Jonel Aleccia, The Associated PressKrishi Jagran Indian Council of Agricultural Research (ICAR) Mahindra Tractors commenced with the registration of participants, followed by a grand inaugural session. The event was hosted by MC Dominic, Founder & Editor-in-Chief of Krishi Jagran, who extended a warm welcome to all attendees and dignitaries. The distinguished guests included . An auspicious lamp-lighting ceremony was held to mark the occasion, signifying the official commencement of this prestigious event. Welcoming all progressive farmers, industry leaders, and esteemed dignitaries, , shared his vision for the MFOI Awards, emphasizing the importance of recognizing farmers. He celebrated the success of last year’s awards, where Raja Ram Tripathi was honored from 36,000 nominations. Dominic expressed his dream of making farmers icons, inspiring even the children of doctors and engineers to pursue farming. He stressed the need for fair prices, support, and recognition to empower farmers and motivate future generations to embrace farming as a respected profession. The Centre on Integrated Rural Development for Asia and the Pacific (CIRDAP) signed an MoU with to scale up and replicate the MFOI initiative in its partner countries. During the MoU signing, , praised efforts in promoting agriculture as a respected career and countering its negative portrayal in society. He emphasized CIRDAP's ongoing work in across 15 member countries, including India and Fiji, and stressed the need to raise awareness among policymakers. Dr. Shekara also noted that July 6th, 2025, would be declared Rural Development Day by the UNGA, coinciding with CIRDAP’s foundation day. He expressed his gratitude to MC Dominic, Mamta Jain, and all the farmers for the opportunity to collaborate on this important initiative. The categories in focus cover a broad spectrum, reflecting the diverse facets of Indian agriculture. To be a part of... , said, “This year marks six decades for Mahindra, a journey driven by our singular mission—transforming agriculture and uplifting farmers. Over these years, we’ve remained committed to providing over 350 tractor variants across India, each tailored to the unique soil conditions of different regions. In the past six decades, we’ve supported over 40 lakh farmers, and this success has been possible only with the unwavering support of our farming community. We are also proud to be part of the MFOI Awards for the second consecutive year, celebrating the success we’ve achieved together with Krishi Jagran and farmers.” He added, “This three-day event is more than just a celebration; it’s an invaluable opportunity for us to connect directly with farmers, understand their needs, and continue refining our products. Since the last event, we’ve conducted roadshows and farmer meetings to ensure our equipment is even more farmer-friendly. Our goal is to inspire more farmers, share knowledge, and make this event a true celebration of agriculture, innovation, and collaboration.” , highlighted that the MFOI Awards celebrate farmers earning over Rs 10 lakh, aligning with the government's goal to double farmers' income and boost agricultural productivity. He emphasized that , through its 113 research centers and 731 KVKs, is working to promote modern agricultural practices and capacity building across India. Agriculture, he noted, should be viewed as an agri-business, a shift that some farmers have already embraced. Over 1,200 farmers will be honored at MFOI, with some even earning ₹1 crore. The event also provides a platform for knowledge sharing, where stakeholders, including policymakers and farmers, discuss ways to increase incomes and inspire others with their success stories. , said, "Today feels like a festival, one that celebrates our farmers. He emphasized the significance of medicinal plants in enhancing the livelihoods and income of Chhattisgarh farmers, while also recognizing their potential to benefit farmers in other states. Dr. Rao shared the board's goal of turning 1 lakh farmers into 'Lakhpatis' by promoting medicinal and aromatic plants. Last year, 20,000 farmers reached this milestone, and already 5,000 farmers have registered this year. He highlighted the suitability of various medicinal plants for different geographical regions and wished all farmers success in their journey of growth." , honored both soldiers and farmers for their contributions, highlighting that 85% of farmers in India remain marginal, and boosting their income is crucial. He stressed the need for collaboration with ICAR and to address key issues: lack of knowledge and technology, unfair pricing, and the rise of fake agricultural inputs. Agarwal urged stakeholders to ensure technology reaches farmers and to empower them to decide where and at what price to sell their produce. He also advised farmers to use QR codes to verify agricultural products, emphasizing that better inputs and knowledge will improve farmers' income. , affirmed that agriculture is the foundation of human development and prosperity. He stressed that both improving farmers' income and making farming profitable are essential for India's growth. The government is working to raise awareness among farmers and improve technology penetration, including at the groundwater level. Mishra also highlighted the crucial role of cooperatives in strengthening farming communities. Following this, Chief Guest Ramesh Chand, Ajay Mishra, and other dignitaries presented trophies to the millionaire farmers in recognition of their exceptional achievements.
None
Marcus Rashford has had issues with every previous Manchester United manager he's played under. That's according to The Athletic writer Andy Mitten, who also claims that fans do not celebrate the academy graduate like they used to. Rashford has missed United's last three Premier League matches as head coach Ruben Amorim and is seemingly keen to leave the club. He revealed in an interview with Henry Winter that he's 'ready for a new challenge' and talkSPORT understands United are open to offers for the player. Some fans expressed their frustrations with the 27-year-old during United's Carabao Cup defeat to Tottenham, unveiling a banner that read: "Excuses. Ta ra, Marcus". Although Amorim has not definitively said Rashford won't return to the team, there are serious questions over his future involvement. Amid the continuous noise, Mitten spoke to talkSPORT and offered insight into the experience of previous managers, including Jose Mourinho and Erik ten Hag, with him. "I do think that the manager has had a big say here," Mitten said on Kick Off. "I think he is doing it his way and he's a smiling assassin, he's a disciplinarian. "And, every previous manager has had issues with Marcus Rashford. I've spoken to them, I know them, they've told me in confidence going back years and years and years. "And then, Marcus confounds those opinions because he has a really good season and from his perspective, and he does have a perspective here, there's not a lot of support for him, I've got to say, among Manchester United fans. "We played at Wolves a couple of days ago, thoroughly miserable there, but if I go back to Wolves at the start of February [last season], I was outside that away end, I couldn't find a single Manchester United fan who wanted him to stay. "When he scored after three or four minutes, those very same fans were singing Marcus Rashford's name, so that is the environment that you're in, and football fans are like that, they change their tune very quickly. "But Marcus Rashford is not celebrated by United fans as he was, his stock is clearly very, very low. I don't think he's had a disastrous start to the season, he was worse last season, but clearly he's nowhere near the levels that he would have hoped for. "Now, if you've got Real Madrid or Paris Saint-Germain or Barcelona lining up going, 'We'd love to take him'... But the reality, the economics of it, they just do not add up. "I don't know what the outcome is going to be, he signed a huge contract, and a lot of them have signed huge contracts, and this makes fans uncomfortable." Rashford has played under Louis van Gaal, Mourinho, Ole Gunnar Solskjaer, Ten Hag and Amorim since making his United debut in 2016. He has also worked with Michael Carrick, Ralf Rangnick and Ruud van Nistelrooy, although the trio were only in caretaker or interim roles. The 60-cap England international has scored seven goals in 24 appearances this season, one of which was Amorim's first in charge. However it remains to be seen when Rashford, who has featured 426 times in total for United, will take to the pitch again. Amorim will once again decide on this on Monday night when they face Newcastle at home in the Premier League, live on talkSPORT .
US Indictment Accuses Two Syrian Officials of Torture at Notorious Prison
A New AI Investment Era? Surging AI Stocks to Watch NowNEW YORK — Shohei Ohtani won his third Most Valuable Player Award and first in the National League, and Aaron Judge earned his second American League honor on Thursday. Ohtani was a unanimous MVP for the third time, receiving all 30 first-place votes and 420 points in voting by the Baseball Writers' Association of America. New York Mets shortstop Francisco Lindor was second with 263 points and Arizona second baseman Ketel Marte third with 229. Judge was a unanimous pick for the first time. Kansas City shortstop Bobby Witt Jr. got all 30 second-place votes for 270 points, and Yankees outfielder Juan Soto was third with 21 third-place votes and 229 points. Ohtani was unanimously voted the AL MVP in 2021 and 2023 as a two-way star for the Los Angeles Angels and finished second to Judge in 2022 voting. He didn't pitch in 2024 following elbow surgery and signed a record $700 million, 10-year contract with the Los Angeles Dodgers last December. Ohtani joined Frank Robinson for Cincinnati in 1961 and Baltimore in 1966 as the only players to win the MVP award in both leagues. He was the first player to twice become an unanimous MVP. He had combined with Atlanta outfielder Ronald Acuña Jr. in 2023 for the first year both MVPs were unanimous. Ohtani hit .310, stole 59 bases and led the NL with 54 homers and 130 RBIs exclusively as a designated hitter, becoming the first player with 50 or more homers and 50 or more stolen bases in a season. He helped the Dodgers to the World Series title, playing the final three games with a torn labrum in his left shoulder. "The ultimate goal from the beginning was to win a World Series, which we are able to accomplish," he said through a translator. "The next goal is for me to do it again and so right now I'm in the middle of rehab and working out and getting stronger." When Ohtani returns to the mound, could he win MVP and the Cy Young Award in the same year? "That would obviously be great, but right now my focus is just to get to get back healthy, come back stronger, get back on the mound and show everybody what I can do," Ohtani said. Ohtani became the first primary DH to win an MVP in a season that started with the revelation his longtime interpreter and friend, Ippei Mizuhara, had stolen nearly $17 million from the star to fund gambling. Ohtani is the 12th player with three or more MVPs, joining Barry Bonds (seven) and Jimmie Foxx, Joe DiMaggio, Stan Musial, Roy Campanella, Yogi Berra, Mickey Mantle, Mike Schmidt, Alex Rodriguez, Albert Pujols and Mike Trout (three each). Balloting was conducted before the postseason. Judge led the major leagues with 58 homers, 144 RBIs and 133 walks while hitting .322. Witt topped the big leagues with a .332 average, hitting 32 homers with 31 stolen bases and 109 RBIs. Soto batted .288 with 41 homers and 109 RBIs. When Judge won his first MVP award in 2022, he received 28 first-place votes while Ohtani got the other two. Judge had discussed the MVP award with Philadelphia's Bryce Harper, the NL winner in 2015 and '21. "I was telling him, `Man, I'm going to try to catch up to you with these MVPs here, man,'" Judge recalled. "He'd say, hopefully, he could stay a couple ahead of me, which I think he'll do." When Judge won his first MVP award in 2022, he received 28 first-place votes while Ohtani got the other two. He is the Yankees' 22nd MVP winner, four more than any other team. Judge was hitting .207 with six homers and 18 RBIs through April, then batted .352 with 52 homers and 126 RBIs in 127 games. "March and April were not my friend this year." Judge said. "Just keep putting in the work and things are going to change. You can't mope. You can't feel sorry for yourself. Especially in New York, nobody's going to feel sorry for you. So you just got to go out there and put up the numbers?" ST. PETERSBURG, Fla. — The St. Petersburg City Council reversed course Thursday on whether to spend more than $23 million to repair the hurricane-shredded roof of the Tampa Bay Rays' ballpark, initially voting narrowly for approval and hours later changing course. The reversal on fixing Tropicana Field came after the council voted to delay consideration of revenue bonds for a proposed new $1.3 billion Rays ballpark. Just two days before, the Pinellas County Commission postponed a vote on its share of the new stadium bonds, leaving that project in limbo. “This is a sad place. I'm really disappointed,” council chair Deborah Figg-Sanders said. “We won’t get there if we keep finding ways we can’t.” The Rays say the lack of progress puts the new stadium plan and the future of Tropicana Field in jeopardy. “I can't say I'm confident about anything,” Rays co-president Brian Auld told the council members. The Trop's translucent fiberglass roof was ripped to pieces on Oct. 9 when Hurricane Milton swept ashore just south of Tampa Bay. There was also significant water damage inside the ballpark, with a city estimate of the total repair costs pegged at $55.7 million. The extensive repairs cannot be finished before the 2026 season, city documents show. The Rays made a deal with the Yankees to play next season at 11,000-seat Steinbrenner Field, New York's spring training home across the bay in Tampa. The initial vote Thursday was to get moving on the roof portion of the repair. Once that's done, crews could begin working on laying down a new baseball field, fixing damaged seating and office areas and a variety of electronic systems — which would require another vote to approve money for the remaining restoration. The subsequent vote reversing funding for the roof repair essentially means the city and Rays must work on an alternative in the coming weeks so that Tropicana Field can possibly be ready for the 2026 season. The city is legally obligated to fix the roof. BRIEFLY PIRATES: Pittsburgh hired Matt Hague as its hitting coach, bringing him back to the team that drafted him in 2008. Hague replaces Andy Haines, who was fired after Pittsburgh finished in the bottom 10 in the majors in every significant statistical category last season, including runs (24th) and home runs (25th), while also striking out a club-record 1,504 times, second-most in the National League behind Colorado. The 39-year-old Hague spent last season as an assistant hitting coach with the Toronto Blue Jays. Get local news delivered to your inbox!
ICMR develops AI tool to predict IVF outcomes in men with infertility